Consistency with Accounting Treatment. The Parties acknowledge and agree that revenues or expenses will not be reflected in Net Profits (or Losses) unless and until such revenues or expenses are recognized by such Party in its financial statements in accordance with GAAP consistently applied by such Party with respect to the transaction(s) in question.
Consistency with Accounting Treatment. All calculations of Development Expenses, Commercialization Expenses and Net Sales hereunder shall be made in accordance with Accounting Standards, including the provisions thereof regarding expense and revenue recognition, as applied by Takeda and Ovid consistently with their application in their respective external financial reporting.
Consistency with Accounting Treatment. All calculations of Research Costs, Development Costs, Joint Commercialization Costs, Operating Profit and Operating Loss hereunder will be made in accordance with GAAP, including the provisions thereof regarding expense recognition, as applied by Unum and SGI consistently with their application in their respective financial reporting.
Consistency with Accounting Treatment. All calculations of Net Profit and Net Loss hereunder shall be made in accordance with Collaboration Accounting Standards, including the provisions thereof regarding expense recognition, as applied by Agensys and SGI consistently with their application in their respective external financial reporting,
Consistency with Accounting Treatment. All calculations of Joint Development Costs, Joint Medical Affairs Costs, Joint Commercialization Costs, Operating Profit and Operating Loss hereunder shall be made in accordance with GAAP, including the provisions thereof regarding expense recognition, as applied by Medivation and AUS consistently with their application in their respective external financial reporting. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the securities and exchange commission pursuant to rule 24b-2 of the securities exchange act of 1934, as amended.
Consistency with Accounting Treatment. All calculations of Joint Commercialization Costs, Operating Profit and Operating Loss hereunder shall be made in accordance with GAAP, including the provisions thereof regarding expense recognition, as applied by Galapagos and Gilead consistently with their application in their respective financial reporting.
Consistency with Accounting Treatment. All calculations of Cost of Goods Sold and Gross Profits hereunder shall be made in accordance with GAAP, including the provisions thereof regarding expense recognition, as applied by BPM consistently with its application in its financial reporting.
Consistency with Accounting Treatment. All calculations of Net Sales hereunder shall be made in accordance with Accounting Standards, including the provisions thereof regarding expense and revenue recognition, as applied by Takeda consistently with their application in its external financial reporting.
Consistency with Accounting Treatment. All calculations of Joint Commercialization Costs and Operating Profit and Operating Loss hereunder shall be made in accordance with GAAP, including the provisions thereof regarding expense recognition, as applied by Galapagos and Gilead consistently with their application in their respective financial reporting. For any costs and expenses charged to the other Party that are to be used in the calculation of Operating Profit and Operating Loss, if they include a xxxx-up on the applicable cost, the Parties will confirm the manner for treating the xxxx-up in such calculation so as to ensure the intended 50%/50% sharing of the Operating Profit (or Loss). Any amounts paid by one Party to the other Party for services or supply activities in connection with the Co-Commercialization will be submitted by the Party that made such payments and not by the Party providing the applicable supply or service, provided that the Party providing the applicable supply or service reports the amount of xxxx-up included, if any.
Consistency with Accounting Treatment. All calculations by Arvinas of Development Costs, Commercialization Costs, Manufacturing Costs and Net Profits or Losses hereunder shall be made in accordance with GAAP, including the provisions thereof regarding expense recognition, as applied by Arvinas consistently with its application in its financial reporting. All calculations by Pfizer of Development Costs, Commercialization Costs, Manufacturing Costs and Net Profits or Losses hereunder shall be made in accordance with GAAP, including the provisions thereof regarding expense recognition, as applied by Pfizer consistently with its application in its financial reporting.
